Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREBOT trial
DRKS00010080Phase 3Withdrawn
- Sponsor
- Heidelberg University Faculty of Medicine
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of botulinum toxin type A (2 arms), sponsored by Heidelberg University Faculty of Medicine. Planned start Feb 2016; status: withdrawn.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on DRKS00010080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010080.